WBR0413
| Author | [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Yazan Daaboul, M.D.)]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Pharmacology |
| Sub Category | SubCategory::Renal |
| Prompt | [[Prompt::A 72-year-old man presents to the physician's office with complaints of dyspnea and bilateral pitting edema. His past medical history is significant for diabetes mellitus, gout, and osteoarthritis. Upon further questioning, the patient explains that he is allergic to several medications. Among the list of medications that he has tried in the past, he recalls he developed skin rash when he was administered sulfonylurea, probenicid, celecoxib, and sulfonamide antibiotics. Following appropriate work-up, the patient is diagnosed with congestive heart failure. The physician decides to prescribe diuretic therapy to relieve the patient's symptoms. Which of the following diuretics is the optimal therapeutic option to treat this patient's congestive heart failure?]] |
| Answer A | AnswerA::Furosemide |
| Answer A Explanation | [[AnswerAExp::Furosemide is a loop diuretic that is associated with sulfa allergy.]] |
| Answer B | AnswerB::Acetazolamide |
| Answer B Explanation | [[AnswerBExp::Acetazolamide is carbonic anhydrase inhibitor that is associated with sulfa allergy.]] |
| Answer C | AnswerC::Ethacrynic acid |
| Answer C Explanation | [[AnswerCExp::Ethacrynic acid is a loop diuretic often prescribed to patients with sulfa allergy.]] |
| Answer D | AnswerD::Hydrochlorothiazide |
| Answer D Explanation | [[AnswerDExp::Hydrochlorothiazide is a thiazides-type diuretic that is associated with sulfa allergy.]] |
| Answer E | AnswerE::Chlorthalidone |
| Answer E Explanation | AnswerEExp::Chlorthalidone is also a thiazides-type diuretic that is associated associated with sulfa allergy. |
| Right Answer | RightAnswer::C |
| Explanation | [[Explanation::Sulfa allergy is a term that describes adverse drug reactions to sulfanamide-based (sulfa) medications. The following list of medications are common sulfa drugs:
Sulfa allergy has an incidence rate of approximately 3 to 5% among the general population. Only a minority of patients with reported sulfa allergy have true type I hypersensitivity reactions, which often occur only with sulfa antibiotics due to the presence of N-1 substituents in the antibiotic formula. On the other hand, non-antibiotic sulfa drugs do not usually contain N-1 substituents, and patients do not usually have true type I hypersensitivity. Instead, they present with delayed manifestations of immunologic or idiosyncratic drug reactions. Clinical manifestations range from a very mild clinical course to potentially fatal outcomes. Symptoms of sulfa allergy include fever, skin rash (maculopapular rash or fixed drug eruption that often develops 1 or 2 weeks following drug administration) along with hepatic, renal, pulmonary, and hematological (thrombocytopenia, leukopenia/agranulocytosis, hemolytic anemia) manifestations. The first step in the management of sulfa allergy is stopping the offending medications followed by symptomatic treatment of the clinical manifestations until complete resolution is attained. Among patients who require dieresis (such as patients with advanced congestive heart failure), ethacrynic acid, a phenoxyacetic acid derivative, is a loop diuretic that is not associated with sulfa allergy and may be prescribed to patients with sulfa allergy for symptomatic relief of fluid overload. Compared with other loop diuretics, ethacrynic acid is associated with higher rates of ototoxicity and is usually only reserved for patients with sulfa allergy who cannot tolerate other commonly used loop or thiazide diuretics. |
| Approved | Approved::Yes |
| Keyword | WBRKeyword::Sulfa allergy, WBRKeyword::Diuretics, WBRKeyword::Ethacrynic acid, WBRKeyword::Sulfa drug, WBRKeyword::Hypersensitivity, WBRKeyword::Congestive heart failure |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |